O	0	8	Deletion	Deletion	NN	B-NP
O	9	11	of	of	IN	B-PP
O	12	17	Tip30	Tip30	NN	B-NP
O	18	23	leads	lead	VBZ	B-VP
O	24	26	to	to	TO	B-PP
O	27	32	rapid	rapid	JJ	B-NP
O	33	48	immortalization	immortalization	NN	I-NP
O	49	51	of	of	IN	B-PP
O	52	58	murine	murine	JJ	B-NP
B-Cell	59	66	mammary	mammary	JJ	I-NP
I-Cell	67	77	epithelial	epithelial	JJ	I-NP
I-Cell	78	83	cells	cell	NNS	I-NP
O	84	87	and	and	CC	O
B-Pathological_formation	88	94	ductal	ductal	JJ	B-NP
I-Pathological_formation	95	106	hyperplasia	hyperplasia	NN	I-NP
O	107	109	in	in	IN	B-PP
O	110	113	the	the	DT	B-NP
B-Organ	114	121	mammary	mammary	JJ	I-NP
I-Organ	122	127	gland	gland	NN	I-NP
O	127	128	.	.	.	O

O	130	144	Transformation	Transformation	NN	B-NP
O	145	147	of	of	IN	B-PP
B-Cell	148	155	mammary	mammary	JJ	B-NP
I-Cell	156	166	epithelial	epithelial	JJ	I-NP
I-Cell	167	172	cells	cell	NNS	I-NP
O	173	174	(	(	(	O
B-Cell	174	178	MECs	MEC	NNS	B-NP
O	178	179	)	)	)	O
O	180	184	from	from	IN	B-PP
O	185	188	the	the	DT	B-NP
O	189	195	normal	normal	JJ	I-NP
O	196	198	to	to	TO	B-PP
O	199	202	the	the	DT	B-NP
B-Cancer	203	213	neoplastic	neoplastic	JJ	I-NP
O	214	219	stage	stage	NN	I-NP
O	220	228	requires	require	VBZ	B-VP
O	229	232	the	the	DT	B-NP
O	233	246	dysregulation	dysregulation	NN	I-NP
O	247	249	of	of	IN	B-PP
B-Cancer	250	255	tumor	tumor	NN	B-NP
O	256	266	suppressor	suppressor	NN	I-NP
O	267	272	genes	gene	NNS	I-NP
O	273	276	and	and	CC	O
O	277	282	proto	proto	AFX	O
O	282	283	-	-	HYPH	O
O	283	292	oncogenes	oncogene	NNS	B-NP
O	292	293	.	.	.	O

O	294	299	Tip30	Tip30	NN	B-NP
O	300	302	is	be	VBZ	B-VP
O	303	304	a	a	DT	B-NP
B-Cancer	305	310	tumor	tumor	NN	I-NP
O	311	321	suppressor	suppressor	NN	I-NP
O	322	326	that	that	WDT	B-NP
O	327	330	can	can	MD	B-VP
O	331	338	inhibit	inhibit	VB	I-VP
O	339	347	estrogen	estrogen	NN	B-NP
O	348	356	receptor	receptor	NN	I-NP
O	356	357	-	-	HYPH	B-VP
O	357	365	mediated	mediate	VBN	B-NP
O	366	379	transcription	transcription	NN	I-NP
O	380	382	in	in	IN	B-PP
B-Cell	383	387	MECs	MEC	NNS	B-NP
O	387	388	,	,	,	O
O	389	392	but	but	CC	O
O	393	396	its	its	PRP$	B-NP
O	397	401	role	role	NN	I-NP
O	402	404	in	in	IN	B-PP
B-Cell	405	408	MEC	MEC	NN	B-NP
O	409	422	proliferation	proliferation	NN	I-NP
O	423	430	remains	remain	VBZ	B-VP
O	431	438	unknown	unknown	JJ	B-ADJP
O	438	439	.	.	.	O

O	440	444	Here	Here	RB	B-ADVP
O	444	445	,	,	,	O
O	446	448	we	we	PRP	B-NP
O	449	453	show	show	VBP	B-VP
O	454	458	that	that	IN	B-SBAR
O	459	467	deleting	delete	VBG	B-VP
O	468	471	the	the	DT	B-NP
O	472	477	Tip30	Tip30	NN	I-NP
O	478	482	gene	gene	NN	I-NP
O	483	488	leads	lead	VBZ	B-VP
O	489	491	to	to	TO	B-PP
B-Pathological_formation	492	498	ductal	ductal	JJ	B-NP
I-Pathological_formation	499	510	hyperplasia	hyperplasia	NN	I-NP
O	511	513	in	in	IN	B-PP
O	514	519	mouse	mouse	NN	B-NP
B-Organ	520	527	mammary	mammary	JJ	I-NP
I-Organ	528	534	glands	gland	NNS	I-NP
O	535	540	early	early	RB	B-ADVP
O	541	543	in	in	IN	B-PP
O	544	548	life	life	NN	B-NP
O	549	552	and	and	CC	O
O	553	562	extensive	extensive	JJ	B-NP
B-Pathological_formation	563	570	mammary	mammary	JJ	I-NP
I-Pathological_formation	571	582	hyperplasia	hyperplasia	NN	I-NP
O	583	587	with	with	IN	B-PP
O	588	591	age	age	NN	B-NP
O	591	592	.	.	.	O

B-Cell	593	598	Tip30	Tip30	NN	B-NP
I-Cell	598	599	(	(	(	O
I-Cell	599	600	-	-	SYM	O
I-Cell	600	601	/	/	SYM	O
I-Cell	601	602	-	-	SYM	O
I-Cell	602	603	)	)	)	O
I-Cell	604	611	mammary	mammary	JJ	B-NP
I-Cell	612	618	glands	gland	NNS	I-NP
O	619	631	transplanted	transplant	VBN	B-VP
O	632	636	into	into	IN	B-PP
O	637	641	wild	wild	JJ	B-NP
O	641	642	-	-	HYPH	I-NP
O	642	646	type	type	NN	I-NP
B-Tissue	647	654	mammary	mammary	JJ	I-NP
I-Tissue	655	658	fat	fat	JJ	I-NP
I-Tissue	659	663	pads	pad	NNS	I-NP
O	664	668	also	also	RB	B-ADVP
O	669	676	display	display	VBP	B-VP
B-Multi-tissue_structure	677	684	mammary	mammary	JJ	B-NP
I-Multi-tissue_structure	685	690	trees	tree	NNS	I-NP
O	691	695	with	with	IN	B-PP
O	696	705	extensive	extensive	JJ	B-NP
B-Pathological_formation	706	712	ductal	ductal	JJ	I-NP
I-Pathological_formation	713	724	hyperplasia	hyperplasia	NN	I-NP
O	724	725	.	.	.	O

O	726	736	Strikingly	Strikingly	RB	B-ADVP
O	736	737	,	,	,	O
O	738	743	Tip30	Tip30	NN	B-NP
O	744	752	deletion	deletion	NN	I-NP
O	753	761	promotes	promote	VBZ	B-VP
O	762	775	proliferation	proliferation	NN	B-NP
O	776	778	of	of	IN	B-PP
O	779	786	primary	primary	JJ	B-NP
B-Cell	787	791	MECs	MEC	NNS	I-NP
O	792	795	and	and	CC	O
O	796	803	results	result	VBZ	B-VP
O	804	806	in	in	IN	B-PP
O	807	812	rapid	rapid	JJ	B-NP
O	813	828	immortalization	immortalization	NN	I-NP
O	829	831	of	of	IN	B-PP
B-Cell	832	836	MECs	MEC	NNS	B-NP
O	837	839	in	in	FW	B-ADVP
O	840	845	vitro	vitro	FW	I-ADVP
O	846	854	relative	relative	JJ	B-ADVP
O	855	857	to	to	TO	B-PP
B-Cell	858	862	wild	wild	JJ	B-NP
I-Cell	862	863	-	-	HYPH	I-NP
I-Cell	863	867	type	type	NN	I-NP
I-Cell	868	873	cells	cell	NNS	I-NP
O	873	874	.	.	.	O

O	875	879	Gene	Gene	NN	B-NP
O	880	885	array	array	NN	I-NP
O	886	894	analysis	analysis	NN	I-NP
O	895	905	identified	identify	VBD	B-VP
O	906	917	significant	significant	JJ	B-NP
O	918	927	increases	increase	NNS	I-NP
O	928	930	in	in	IN	B-PP
O	931	934	the	the	DT	B-NP
O	935	945	expression	expression	NN	I-NP
O	946	948	of	of	IN	B-PP
B-Tissue	949	956	mammary	mammary	JJ	B-NP
I-Tissue	957	967	epithelial	epithelial	JJ	I-NP
O	968	974	growth	growth	NN	I-NP
O	975	982	factors	factor	NNS	I-NP
O	983	988	Wisp2	Wisp2	NN	B-NP
O	989	992	and	and	CC	I-NP
O	993	996	Igf	Igf	NN	I-NP
O	996	997	-	-	HYPH	B-NP
O	997	998	1	1	CD	I-NP
O	999	1001	in	in	IN	B-PP
B-Cell	1002	1007	Tip30	Tip30	NN	B-NP
I-Cell	1007	1008	(	(	(	O
I-Cell	1008	1009	-	-	SYM	O
I-Cell	1009	1010	/	/	SYM	O
I-Cell	1010	1011	-	-	SYM	O
I-Cell	1011	1012	)	)	)	O
I-Cell	1013	1018	cells	cell	NNS	B-NP
O	1018	1019	.	.	.	O

O	1020	1029	Knockdown	Knockdown	NN	B-NP
O	1030	1032	of	of	IN	B-PP
O	1033	1039	either	either	CC	O
O	1040	1045	Wisp2	Wisp2	NN	B-NP
O	1046	1048	or	or	CC	I-NP
O	1049	1052	Igf	Igf	NN	I-NP
O	1052	1053	-	-	HYPH	B-NP
O	1053	1054	1	1	CD	I-NP
O	1055	1060	using	use	VBG	B-VP
O	1061	1066	short	short	JJ	B-NP
O	1067	1078	interfering	interfere	VBG	I-NP
O	1079	1082	RNA	RNA	NN	I-NP
O	1083	1095	dramatically	dramatically	RB	B-ADVP
O	1096	1105	inhibited	inhibit	VBD	B-VP
O	1106	1119	proliferation	proliferation	NN	B-NP
O	1120	1122	of	of	IN	B-PP
B-Cell	1123	1128	Tip30	Tip30	NN	B-NP
I-Cell	1128	1129	(	(	(	O
I-Cell	1129	1130	-	-	SYM	O
I-Cell	1130	1131	/	/	SYM	O
I-Cell	1131	1132	-	-	SYM	O
I-Cell	1132	1133	)	)	)	O
I-Cell	1134	1139	cells	cell	NNS	B-NP
O	1139	1140	.	.	.	O

O	1141	1149	Together	Together	RB	B-ADVP
O	1149	1150	,	,	,	O
O	1151	1156	these	these	DT	B-NP
O	1157	1164	results	result	NNS	I-NP
O	1165	1172	suggest	suggest	VBP	B-VP
O	1173	1177	that	that	IN	B-SBAR
O	1178	1183	Tip30	Tip30	NN	B-NP
O	1184	1186	is	be	VBZ	B-VP
O	1187	1189	an	an	DT	B-NP
O	1190	1199	intrinsic	intrinsic	JJ	I-NP
O	1200	1203	and	and	CC	I-NP
O	1204	1212	negative	negative	JJ	I-NP
O	1213	1222	regulator	regulator	NN	I-NP
O	1223	1225	of	of	IN	B-PP
B-Cell	1226	1229	MEC	MEC	NN	B-NP
O	1230	1243	proliferation	proliferation	NN	I-NP
O	1244	1250	partly	partly	RB	B-ADVP
O	1251	1258	through	through	IN	B-PP
O	1259	1262	the	the	DT	B-NP
O	1263	1273	inhibition	inhibition	NN	I-NP
O	1274	1276	of	of	IN	B-PP
O	1277	1282	Wisp2	Wisp2	NN	B-NP
O	1283	1286	and	and	CC	I-NP
O	1287	1290	Igf	Igf	NN	I-NP
O	1290	1291	-	-	HYPH	B-NP
O	1291	1292	1	1	CD	I-NP
O	1293	1303	expression	expression	NN	I-NP
O	1303	1304	,	,	,	O
O	1305	1308	and	and	CC	O
O	1309	1312	its	its	PRP$	B-NP
O	1313	1320	absence	absence	NN	I-NP
O	1321	1323	in	in	IN	B-PP
O	1324	1327	the	the	DT	B-NP
B-Organ	1328	1335	mammary	mammary	JJ	I-NP
I-Organ	1336	1341	gland	gland	NN	I-NP
O	1342	1345	may	may	MD	B-VP
O	1346	1356	predispose	predispose	VB	I-VP
B-Cell	1357	1361	MECs	MEC	NNS	B-NP
O	1362	1364	to	to	TO	B-PP
B-Cancer	1365	1375	neoplastic	neoplastic	JJ	B-NP
O	1376	1390	transformation	transformation	NN	I-NP
O	1390	1391	.	.	.	O

